12:00 AM
 | 
Mar 19, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Lorcaserin regulatory update

FDA's Endocrinologic and Metabolic Drugs Advisory Committee will meet on May 10 to discuss an NDA from...

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >